Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112470849 | 11247084 | 9 | F | 20150625 | 20160708 | 20150708 | 20160721 | PER | US-PFIZER INC-2015221624 | PFIZER | 67.00 | YR | F | Y | 80.00000 | KG | 20160721 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112470849 | 11247084 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 112470849 | 11247084 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG EVERY DAY (4 WEEKS ON/2 WEEKS OFF) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | ||||||
| 112470849 | 11247084 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, CYCLIC (28 DAYS ON/14 DAYS OFF ) | Y | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 112470849 | 11247084 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, CYCLIC (4 WEEKS ON, 2 WEEKS OFF) | Y | 21938 | 25 | MG | CAPSULE, HARD | ||||||
| 112470849 | 11247084 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | Y | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 112470849 | 11247084 | 6 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, DAILY | Y | 21938 | 25 | MG | CAPSULE, HARD | ||||||
| 112470849 | 11247084 | 7 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (28 DAYS ON/14 DAYS OFF.) | Y | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 112470849 | 11247084 | 8 | C | PEPCID | FAMOTIDINE | 1 | UNK | 0 | |||||||||||
| 112470849 | 11247084 | 9 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112470849 | 11247084 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112470849 | 11247084 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112470849 | 11247084 | Arthralgia | |
| 112470849 | 11247084 | Aspartate aminotransferase increased | |
| 112470849 | 11247084 | Biliary tract disorder | |
| 112470849 | 11247084 | Blood bilirubin increased | |
| 112470849 | 11247084 | Blood pressure fluctuation | |
| 112470849 | 11247084 | Decreased appetite | |
| 112470849 | 11247084 | Erythema | |
| 112470849 | 11247084 | Fatigue | |
| 112470849 | 11247084 | Joint stiffness | |
| 112470849 | 11247084 | Nausea | |
| 112470849 | 11247084 | Neutropenia | |
| 112470849 | 11247084 | Palmar-plantar erythrodysaesthesia syndrome | |
| 112470849 | 11247084 | Rash pruritic | |
| 112470849 | 11247084 | Swelling face | |
| 112470849 | 11247084 | Thrombocytopenia | |
| 112470849 | 11247084 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112470849 | 11247084 | 1 | 20150622 | 20150712 | 0 | |
| 112470849 | 11247084 | 2 | 20150729 | 0 | ||
| 112470849 | 11247084 | 3 | 20150625 | 20151008 | 0 | |
| 112470849 | 11247084 | 5 | 20151019 | 0 | ||
| 112470849 | 11247084 | 6 | 20150521 | 0 |